News Briefing channel feed – Endpoints News

News Briefing channel feed

Rona Therapeutics raises $35M; Actuate now plans for $22M IPO

10 months ago

Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate

10 months ago

SK to pay up to $571M in new radiopharma deal; Aslan lets go of all employees

10 months ago

SOTIO, Biocytogen to jointly develop antibodies; Pliant's mid-stage liver disease data

10 months ago

Evofem inks women’s health deal; AusperBio brings in $37M

10 months ago

Ideaya raises $302M; AbbVie to seek approval in giant cell arteritis

10 months ago

Faron details clinical plans for MDS drug; Cara to seek 'strategic' options

10 months ago

Ideaya aims to raise $263M; Immuneel extends Series A with $12M

10 months ago

Kymera's stock rises after derma investigation expands; Ligand buys Apeiron

10 months ago

Vanqua raises $45M; Aerovate to look for strategic alternatives

10 months ago

Innovent reworks deal with IASO; Granza raises $7M

11 months ago

Yuhan, Ubix ink licensing deal; Xenpozyme's royalty deal

11 months ago

Tracon to seek ‘strategic’ options; Ovid to lay off 17 workers

11 months ago

Savara’s $100M offering; New biotech to test Eisai drug in Ph2

11 months ago

Recursion’s $200M offering; Sanofi invests $40M in Vigil Neuroscience

11 months ago

Taysha’s $75M offering; Augustine raises €17M

11 months ago

Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials

11 months ago

Corrected: Entrada raises $100M for Duchenne development; eFFECTOR winds down

11 months ago

Layoffs at Ginkgo and Xellia; Melodia and Alivexis ink $275M partnership

11 months ago

Forbion's new €75M fund; Cara Therapeutics to cut workforce after trial failure

11 months ago

A new obesity biotech; UroGen aims to raise $107M

11 months ago

Argenx drops post-Covid syndrome program; Mirum picks a dose for bile duct disease drug

11 months ago

Takeda signs option deal for TKI inhibitor; Enveda's $55M raise

11 months ago

Avidity’s $300M offering; Rapport raises $174M

11 months ago

First page Previous page 6 7 8910 11 12 Next page Last page